Cochlear-backed epilepsy medtech Epiminder’s shares on the slide after $125m public offer

Shares in Melbourne-based medtech Epiminder (ASX: EPI), a company backed by hearing technology giant Cochlear (ASX: COH), have struggled to push past their issue price following a $125 million initial public offering (IPO) completed at the end of last month.

The shares, which were issued at…


Click here to view the original article.